nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—MAOB—alcohol dependence	0.204	0.399	CbGaD
Amphetamine—SLC6A3—alcohol dependence	0.123	0.241	CbGaD
Amphetamine—SLC6A3—Citalopram—alcohol dependence	0.0984	0.354	CbGbCtD
Amphetamine—SLC6A4—alcohol dependence	0.0922	0.18	CbGaD
Amphetamine—DRD2—alcohol dependence	0.0917	0.179	CbGaD
Amphetamine—SLC6A4—Citalopram—alcohol dependence	0.0861	0.309	CbGbCtD
Amphetamine—SLC6A2—Citalopram—alcohol dependence	0.072	0.259	CbGbCtD
Amphetamine—CYP2D6—Citalopram—alcohol dependence	0.0216	0.0776	CbGbCtD
Amphetamine—CARTPT—nerve—alcohol dependence	0.00448	0.087	CbGeAlD
Amphetamine—SLC6A2—locus ceruleus—alcohol dependence	0.00311	0.0604	CbGeAlD
Amphetamine—Sudden death—Acamprosate—alcohol dependence	0.00197	0.0269	CcSEcCtD
Amphetamine—Cardiomyopathy—Acamprosate—alcohol dependence	0.00197	0.0269	CcSEcCtD
Amphetamine—CARTPT—brainstem—alcohol dependence	0.00192	0.0374	CbGeAlD
Amphetamine—CARTPT—forebrain—alcohol dependence	0.00185	0.0361	CbGeAlD
Amphetamine—CARTPT—adrenal cortex—alcohol dependence	0.00172	0.0334	CbGeAlD
Amphetamine—SLC6A2—autonomic nervous system—alcohol dependence	0.00165	0.0321	CbGeAlD
Amphetamine—Psychotic disorder—Disulfiram—alcohol dependence	0.00145	0.0198	CcSEcCtD
Amphetamine—CARTPT—blood—alcohol dependence	0.00124	0.0241	CbGeAlD
Amphetamine—Erectile dysfunction—Disulfiram—alcohol dependence	0.00118	0.0161	CcSEcCtD
Amphetamine—Sudden death—Citalopram—alcohol dependence	0.00118	0.0161	CcSEcCtD
Amphetamine—SLC6A3—nerve—alcohol dependence	0.00115	0.0224	CbGeAlD
Amphetamine—Accidental injury—Acamprosate—alcohol dependence	0.00114	0.0155	CcSEcCtD
Amphetamine—CARTPT—endocrine gland—alcohol dependence	0.00108	0.0209	CbGeAlD
Amphetamine—CARTPT—testis—alcohol dependence	0.00103	0.0199	CbGeAlD
Amphetamine—Muscle twitching—Acamprosate—alcohol dependence	0.00102	0.014	CcSEcCtD
Amphetamine—TAAR1—nervous system—alcohol dependence	0.00101	0.0196	CbGeAlD
Amphetamine—CARTPT—nervous system—alcohol dependence	0.00101	0.0196	CbGeAlD
Amphetamine—MAOB—nerve—alcohol dependence	0.001	0.0195	CbGeAlD
Amphetamine—CARTPT—central nervous system—alcohol dependence	0.000969	0.0188	CbGeAlD
Amphetamine—TAAR1—central nervous system—alcohol dependence	0.000969	0.0188	CbGeAlD
Amphetamine—Muscle twitching—Naltrexone—alcohol dependence	0.000969	0.0132	CcSEcCtD
Amphetamine—Blood pressure increased—Naltrexone—alcohol dependence	0.000951	0.013	CcSEcCtD
Amphetamine—CARTPT—cerebellum—alcohol dependence	0.000948	0.0184	CbGeAlD
Amphetamine—Tooth disorder—Citalopram—alcohol dependence	0.000929	0.0127	CcSEcCtD
Amphetamine—SLC6A2—nerve—alcohol dependence	0.000928	0.018	CbGeAlD
Amphetamine—DRD2—nerve—alcohol dependence	0.000846	0.0164	CbGeAlD
Amphetamine—Euphoric mood—Naltrexone—alcohol dependence	0.000817	0.0112	CcSEcCtD
Amphetamine—Injury—Acamprosate—alcohol dependence	0.000794	0.0109	CcSEcCtD
Amphetamine—Libido decreased—Acamprosate—alcohol dependence	0.000787	0.0108	CcSEcCtD
Amphetamine—CARTPT—brain—alcohol dependence	0.00077	0.015	CbGeAlD
Amphetamine—Libido decreased—Naltrexone—alcohol dependence	0.000745	0.0102	CcSEcCtD
Amphetamine—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.000724	0.0099	CcSEcCtD
Amphetamine—Psychotic disorder—Acamprosate—alcohol dependence	0.000713	0.00974	CcSEcCtD
Amphetamine—Speech disorder—Citalopram—alcohol dependence	0.000701	0.00958	CcSEcCtD
Amphetamine—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.000685	0.00936	CcSEcCtD
Amphetamine—Accidental injury—Citalopram—alcohol dependence	0.000681	0.00931	CcSEcCtD
Amphetamine—Psychotic disorder—Naltrexone—alcohol dependence	0.000674	0.00922	CcSEcCtD
Amphetamine—Viral infection—Citalopram—alcohol dependence	0.000667	0.00912	CcSEcCtD
Amphetamine—Dysmenorrhoea—Citalopram—alcohol dependence	0.000663	0.00906	CcSEcCtD
Amphetamine—Irritability—Naltrexone—alcohol dependence	0.000659	0.00901	CcSEcCtD
Amphetamine—SLC18A2—brainstem—alcohol dependence	0.000653	0.0127	CbGeAlD
Amphetamine—Somnolence—Disulfiram—alcohol dependence	0.000647	0.00885	CcSEcCtD
Amphetamine—Dyskinesia—Citalopram—alcohol dependence	0.000641	0.00877	CcSEcCtD
Amphetamine—Abdominal pain upper—Naltrexone—alcohol dependence	0.000631	0.00862	CcSEcCtD
Amphetamine—SLC18A2—forebrain—alcohol dependence	0.00063	0.0123	CbGeAlD
Amphetamine—Fatigue—Disulfiram—alcohol dependence	0.000628	0.00858	CcSEcCtD
Amphetamine—Muscle twitching—Citalopram—alcohol dependence	0.000614	0.00839	CcSEcCtD
Amphetamine—Blood pressure increased—Citalopram—alcohol dependence	0.000603	0.00824	CcSEcCtD
Amphetamine—Erectile dysfunction—Acamprosate—alcohol dependence	0.000581	0.00794	CcSEcCtD
Amphetamine—Photosensitivity reaction—Acamprosate—alcohol dependence	0.000576	0.00787	CcSEcCtD
Amphetamine—Weight decreased—Acamprosate—alcohol dependence	0.000571	0.0078	CcSEcCtD
Amphetamine—Depression—Acamprosate—alcohol dependence	0.000561	0.00767	CcSEcCtD
Amphetamine—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000555	0.00758	CcSEcCtD
Amphetamine—Myocardial infarction—Acamprosate—alcohol dependence	0.000551	0.00754	CcSEcCtD
Amphetamine—Urinary tract infection—Acamprosate—alcohol dependence	0.000547	0.00747	CcSEcCtD
Amphetamine—Weight decreased—Naltrexone—alcohol dependence	0.00054	0.00738	CcSEcCtD
Amphetamine—Lightheadedness—Citalopram—alcohol dependence	0.000539	0.00737	CcSEcCtD
Amphetamine—Sweating—Acamprosate—alcohol dependence	0.000539	0.00737	CcSEcCtD
Amphetamine—Depression—Naltrexone—alcohol dependence	0.000531	0.00725	CcSEcCtD
Amphetamine—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000525	0.00717	CcSEcCtD
Amphetamine—Asthenia—Disulfiram—alcohol dependence	0.000523	0.00714	CcSEcCtD
Amphetamine—Myocardial infarction—Naltrexone—alcohol dependence	0.000522	0.00713	CcSEcCtD
Amphetamine—Euphoric mood—Citalopram—alcohol dependence	0.000518	0.00708	CcSEcCtD
Amphetamine—Urinary tract infection—Naltrexone—alcohol dependence	0.000517	0.00707	CcSEcCtD
Amphetamine—SLC6A3—brainstem—alcohol dependence	0.000494	0.0096	CbGeAlD
Amphetamine—Dizziness—Disulfiram—alcohol dependence	0.000482	0.00658	CcSEcCtD
Amphetamine—SLC6A3—forebrain—alcohol dependence	0.000477	0.00927	CbGeAlD
Amphetamine—Injury—Citalopram—alcohol dependence	0.000476	0.00651	CcSEcCtD
Amphetamine—Libido decreased—Citalopram—alcohol dependence	0.000472	0.00645	CcSEcCtD
Amphetamine—Rash—Disulfiram—alcohol dependence	0.000459	0.00628	CcSEcCtD
Amphetamine—Headache—Disulfiram—alcohol dependence	0.000456	0.00624	CcSEcCtD
Amphetamine—SLC6A4—brainstem—alcohol dependence	0.000453	0.0088	CbGeAlD
Amphetamine—Cerebrovascular accident—Citalopram—alcohol dependence	0.000447	0.0061	CcSEcCtD
Amphetamine—SLC18A2—digestive system—alcohol dependence	0.000442	0.0086	CbGeAlD
Amphetamine—SLC6A4—forebrain—alcohol dependence	0.000437	0.00849	CbGeAlD
Amphetamine—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000434	0.00593	CcSEcCtD
Amphetamine—Tension—Acamprosate—alcohol dependence	0.000431	0.00589	CcSEcCtD
Amphetamine—Affect lability—Citalopram—alcohol dependence	0.000431	0.00589	CcSEcCtD
Amphetamine—MAOB—brainstem—alcohol dependence	0.00043	0.00837	CbGeAlD
Amphetamine—Psychotic disorder—Citalopram—alcohol dependence	0.000427	0.00584	CcSEcCtD
Amphetamine—Nervousness—Acamprosate—alcohol dependence	0.000427	0.00583	CcSEcCtD
Amphetamine—SLC18A2—blood—alcohol dependence	0.000421	0.00819	CbGeAlD
Amphetamine—Irritability—Citalopram—alcohol dependence	0.000418	0.00571	CcSEcCtD
Amphetamine—SLC18A2—midbrain—alcohol dependence	0.000416	0.00809	CbGeAlD
Amphetamine—MAOB—forebrain—alcohol dependence	0.000415	0.00807	CbGeAlD
Amphetamine—Mood swings—Citalopram—alcohol dependence	0.000415	0.00566	CcSEcCtD
Amphetamine—Tremor—Acamprosate—alcohol dependence	0.000412	0.00563	CcSEcCtD
Amphetamine—Tension—Naltrexone—alcohol dependence	0.000408	0.00558	CcSEcCtD
Amphetamine—Agitation—Acamprosate—alcohol dependence	0.000404	0.00552	CcSEcCtD
Amphetamine—Nervousness—Naltrexone—alcohol dependence	0.000404	0.00552	CcSEcCtD
Amphetamine—Angioedema—Acamprosate—alcohol dependence	0.000402	0.00549	CcSEcCtD
Amphetamine—Abdominal pain upper—Citalopram—alcohol dependence	0.0004	0.00546	CcSEcCtD
Amphetamine—SLC6A2—brainstem—alcohol dependence	0.000399	0.00775	CbGeAlD
Amphetamine—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000394	0.00538	CcSEcCtD
Amphetamine—Tremor—Naltrexone—alcohol dependence	0.00039	0.00533	CcSEcCtD
Amphetamine—Palpitations—Acamprosate—alcohol dependence	0.000388	0.00531	CcSEcCtD
Amphetamine—MAOB—adrenal cortex—alcohol dependence	0.000385	0.00748	CbGeAlD
Amphetamine—SLC6A2—forebrain—alcohol dependence	0.000385	0.00748	CbGeAlD
Amphetamine—Agitation—Naltrexone—alcohol dependence	0.000382	0.00522	CcSEcCtD
Amphetamine—Convulsion—Acamprosate—alcohol dependence	0.000381	0.0052	CcSEcCtD
Amphetamine—Angioedema—Naltrexone—alcohol dependence	0.00038	0.00519	CcSEcCtD
Amphetamine—Hypertension—Acamprosate—alcohol dependence	0.00038	0.00519	CcSEcCtD
Amphetamine—Chest pain—Acamprosate—alcohol dependence	0.000374	0.00511	CcSEcCtD
Amphetamine—Anxiety—Acamprosate—alcohol dependence	0.000373	0.0051	CcSEcCtD
Amphetamine—Pargyline—MAOB—alcohol dependence	0.000372	0.0827	CrCbGaD
Amphetamine—Palpitations—Naltrexone—alcohol dependence	0.000368	0.00502	CcSEcCtD
Amphetamine—Dry mouth—Acamprosate—alcohol dependence	0.000366	0.005	CcSEcCtD
Amphetamine—SLC18A2—endocrine gland—alcohol dependence	0.000366	0.00711	CbGeAlD
Amphetamine—DRD2—brainstem—alcohol dependence	0.000363	0.00706	CbGeAlD
Amphetamine—Convulsion—Naltrexone—alcohol dependence	0.00036	0.00492	CcSEcCtD
Amphetamine—Hypertension—Naltrexone—alcohol dependence	0.000359	0.00491	CcSEcCtD
Amphetamine—Anaphylactic shock—Acamprosate—alcohol dependence	0.000359	0.0049	CcSEcCtD
Amphetamine—Infection—Acamprosate—alcohol dependence	0.000356	0.00487	CcSEcCtD
Amphetamine—Chest pain—Naltrexone—alcohol dependence	0.000354	0.00484	CcSEcCtD
Amphetamine—Anxiety—Naltrexone—alcohol dependence	0.000353	0.00482	CcSEcCtD
Amphetamine—MAOB—cardiovascular system—alcohol dependence	0.000351	0.00683	CbGeAlD
Amphetamine—DRD2—forebrain—alcohol dependence	0.00035	0.00681	CbGeAlD
Amphetamine—Tachycardia—Acamprosate—alcohol dependence	0.00035	0.00479	CcSEcCtD
Amphetamine—SLC18A2—testis—alcohol dependence	0.000349	0.00678	CbGeAlD
Amphetamine—Erectile dysfunction—Citalopram—alcohol dependence	0.000348	0.00476	CcSEcCtD
Amphetamine—Hyperhidrosis—Acamprosate—alcohol dependence	0.000347	0.00474	CcSEcCtD
Amphetamine—Dry mouth—Naltrexone—alcohol dependence	0.000346	0.00473	CcSEcCtD
Amphetamine—Photosensitivity reaction—Citalopram—alcohol dependence	0.000345	0.00472	CcSEcCtD
Amphetamine—SLC22A3—gonad—alcohol dependence	0.000344	0.0067	CbGeAlD
Amphetamine—Weight decreased—Citalopram—alcohol dependence	0.000342	0.00468	CcSEcCtD
Amphetamine—SLC18A2—nervous system—alcohol dependence	0.000342	0.00665	CbGeAlD
Amphetamine—Anorexia—Acamprosate—alcohol dependence	0.000342	0.00467	CcSEcCtD
Amphetamine—Anaphylactic shock—Naltrexone—alcohol dependence	0.000339	0.00464	CcSEcCtD
Amphetamine—Infection—Naltrexone—alcohol dependence	0.000337	0.00461	CcSEcCtD
Amphetamine—Depression—Citalopram—alcohol dependence	0.000336	0.0046	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000334	0.00457	CcSEcCtD
Amphetamine—Acute coronary syndrome—Citalopram—alcohol dependence	0.000332	0.00454	CcSEcCtD
Amphetamine—Tachycardia—Naltrexone—alcohol dependence	0.000331	0.00453	CcSEcCtD
Amphetamine—Myocardial infarction—Citalopram—alcohol dependence	0.000331	0.00452	CcSEcCtD
Amphetamine—SLC18A2—liver—alcohol dependence	0.00033	0.00641	CbGeAlD
Amphetamine—SLC18A2—central nervous system—alcohol dependence	0.000329	0.0064	CbGeAlD
Amphetamine—Hyperhidrosis—Naltrexone—alcohol dependence	0.000328	0.00448	CcSEcCtD
Amphetamine—Urinary tract infection—Citalopram—alcohol dependence	0.000328	0.00448	CcSEcCtD
Amphetamine—Insomnia—Acamprosate—alcohol dependence	0.000324	0.00443	CcSEcCtD
Amphetamine—Anorexia—Naltrexone—alcohol dependence	0.000324	0.00442	CcSEcCtD
Amphetamine—Sweating—Citalopram—alcohol dependence	0.000323	0.00442	CcSEcCtD
Amphetamine—SLC18A2—cerebellum—alcohol dependence	0.000322	0.00626	CbGeAlD
Amphetamine—Dyspnoea—Acamprosate—alcohol dependence	0.00032	0.00437	CcSEcCtD
Amphetamine—Somnolence—Acamprosate—alcohol dependence	0.000319	0.00436	CcSEcCtD
Amphetamine—Dyspepsia—Acamprosate—alcohol dependence	0.000316	0.00432	CcSEcCtD
Amphetamine—SLC6A3—midbrain—alcohol dependence	0.000315	0.00612	CbGeAlD
Amphetamine—Decreased appetite—Acamprosate—alcohol dependence	0.000312	0.00426	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00031	0.00423	CcSEcCtD
Amphetamine—Insomnia—Naltrexone—alcohol dependence	0.000307	0.0042	CcSEcCtD
Amphetamine—Constipation—Acamprosate—alcohol dependence	0.000307	0.00419	CcSEcCtD
Amphetamine—SLC6A4—digestive system—alcohol dependence	0.000307	0.00596	CbGeAlD
Amphetamine—Dyspnoea—Naltrexone—alcohol dependence	0.000303	0.00414	CcSEcCtD
Amphetamine—SLC22A5—adrenal cortex—alcohol dependence	0.000302	0.00588	CbGeAlD
Amphetamine—Somnolence—Naltrexone—alcohol dependence	0.000302	0.00412	CcSEcCtD
Amphetamine—SLC6A2—gonad—alcohol dependence	0.000295	0.00574	CbGeAlD
Amphetamine—Decreased appetite—Naltrexone—alcohol dependence	0.000295	0.00403	CcSEcCtD
Amphetamine—CYP2A6—liver—alcohol dependence	0.000294	0.00572	CbGeAlD
Amphetamine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000293	0.00401	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000293	0.004	CcSEcCtD
Amphetamine—Fatigue—Naltrexone—alcohol dependence	0.000293	0.004	CcSEcCtD
Amphetamine—SLC6A4—blood—alcohol dependence	0.000292	0.00568	CbGeAlD
Amphetamine—MAOB—digestive system—alcohol dependence	0.000292	0.00567	CbGeAlD
Amphetamine—Benzyl alcohol—ALDH2—alcohol dependence	0.000291	0.0648	CrCbGaD
Amphetamine—Constipation—Naltrexone—alcohol dependence	0.00029	0.00397	CcSEcCtD
Amphetamine—SLC6A4—midbrain—alcohol dependence	0.000288	0.00561	CbGeAlD
Amphetamine—CYP2A6—cerebellum—alcohol dependence	0.000288	0.00559	CbGeAlD
Amphetamine—Erythema multiforme—Citalopram—alcohol dependence	0.000286	0.00391	CcSEcCtD
Amphetamine—Urticaria—Acamprosate—alcohol dependence	0.000285	0.00389	CcSEcCtD
Amphetamine—Body temperature increased—Acamprosate—alcohol dependence	0.000284	0.00388	CcSEcCtD
Amphetamine—Abdominal pain—Acamprosate—alcohol dependence	0.000284	0.00388	CcSEcCtD
Amphetamine—MAOB—blood—alcohol dependence	0.000278	0.0054	CbGeAlD
Amphetamine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000278	0.00379	CcSEcCtD
Amphetamine—MAOB—midbrain—alcohol dependence	0.000274	0.00533	CbGeAlD
Amphetamine—Urticaria—Naltrexone—alcohol dependence	0.00027	0.00369	CcSEcCtD
Amphetamine—Body temperature increased—Naltrexone—alcohol dependence	0.000268	0.00367	CcSEcCtD
Amphetamine—Abdominal pain—Naltrexone—alcohol dependence	0.000268	0.00367	CcSEcCtD
Amphetamine—Hypersensitivity—Acamprosate—alcohol dependence	0.000264	0.00361	CcSEcCtD
Amphetamine—SLC6A3—testis—alcohol dependence	0.000264	0.00513	CbGeAlD
Amphetamine—SLC18A2—brain—alcohol dependence	0.000262	0.00508	CbGeAlD
Amphetamine—Pargyline—MAOA—alcohol dependence	0.000261	0.058	CrCbGaD
Amphetamine—SLC22A3—endocrine gland—alcohol dependence	0.00026	0.00506	CbGeAlD
Amphetamine—SLC6A3—nervous system—alcohol dependence	0.000259	0.00503	CbGeAlD
Amphetamine—Tension—Citalopram—alcohol dependence	0.000259	0.00353	CcSEcCtD
Amphetamine—Asthenia—Acamprosate—alcohol dependence	0.000257	0.00352	CcSEcCtD
Amphetamine—Diethylpropion—SLC6A3—alcohol dependence	0.000256	0.057	CrCbGaD
Amphetamine—Nervousness—Citalopram—alcohol dependence	0.000256	0.0035	CcSEcCtD
Amphetamine—SLC6A4—endocrine gland—alcohol dependence	0.000253	0.00493	CbGeAlD
Amphetamine—Hypersensitivity—Naltrexone—alcohol dependence	0.00025	0.00342	CcSEcCtD
Amphetamine—SLC6A3—central nervous system—alcohol dependence	0.000249	0.00484	CbGeAlD
Amphetamine—SLC22A3—testis—alcohol dependence	0.000248	0.00483	CbGeAlD
Amphetamine—Tremor—Citalopram—alcohol dependence	0.000247	0.00337	CcSEcCtD
Amphetamine—Diarrhoea—Acamprosate—alcohol dependence	0.000245	0.00335	CcSEcCtD
Amphetamine—SLC22A3—nervous system—alcohol dependence	0.000244	0.00474	CbGeAlD
Amphetamine—Asthenia—Naltrexone—alcohol dependence	0.000244	0.00333	CcSEcCtD
Amphetamine—SLC6A3—cerebellum—alcohol dependence	0.000244	0.00473	CbGeAlD
Amphetamine—Agitation—Citalopram—alcohol dependence	0.000242	0.00331	CcSEcCtD
Amphetamine—MAOB—endocrine gland—alcohol dependence	0.000241	0.00468	CbGeAlD
Amphetamine—Angioedema—Citalopram—alcohol dependence	0.000241	0.00329	CcSEcCtD
Amphetamine—Tranylcypromine—MAOB—alcohol dependence	0.00024	0.0533	CrCbGaD
Amphetamine—Dizziness—Acamprosate—alcohol dependence	0.000237	0.00324	CcSEcCtD
Amphetamine—SLC6A4—nervous system—alcohol dependence	0.000237	0.00461	CbGeAlD
Amphetamine—SLC22A3—liver—alcohol dependence	0.000235	0.00456	CbGeAlD
Amphetamine—SLC22A3—central nervous system—alcohol dependence	0.000235	0.00456	CbGeAlD
Amphetamine—CYP2A6—brain—alcohol dependence	0.000234	0.00454	CbGeAlD
Amphetamine—Palpitations—Citalopram—alcohol dependence	0.000233	0.00318	CcSEcCtD
Amphetamine—Diarrhoea—Naltrexone—alcohol dependence	0.000232	0.00317	CcSEcCtD
Amphetamine—DRD2—midbrain—alcohol dependence	0.000231	0.0045	CbGeAlD
Amphetamine—MAOB—testis—alcohol dependence	0.00023	0.00447	CbGeAlD
Amphetamine—SLC22A5—digestive system—alcohol dependence	0.000229	0.00445	CbGeAlD
Amphetamine—SLC6A4—central nervous system—alcohol dependence	0.000228	0.00444	CbGeAlD
Amphetamine—Convulsion—Citalopram—alcohol dependence	0.000228	0.00312	CcSEcCtD
Amphetamine—Vomiting—Acamprosate—alcohol dependence	0.000228	0.00312	CcSEcCtD
Amphetamine—Hypertension—Citalopram—alcohol dependence	0.000228	0.00311	CcSEcCtD
Amphetamine—Rash—Acamprosate—alcohol dependence	0.000226	0.00309	CcSEcCtD
Amphetamine—Dermatitis—Acamprosate—alcohol dependence	0.000226	0.00309	CcSEcCtD
Amphetamine—MAOB—nervous system—alcohol dependence	0.000225	0.00438	CbGeAlD
Amphetamine—Headache—Acamprosate—alcohol dependence	0.000225	0.00307	CcSEcCtD
Amphetamine—Dizziness—Naltrexone—alcohol dependence	0.000224	0.00307	CcSEcCtD
Amphetamine—Chest pain—Citalopram—alcohol dependence	0.000224	0.00307	CcSEcCtD
Amphetamine—Anxiety—Citalopram—alcohol dependence	0.000224	0.00306	CcSEcCtD
Amphetamine—SLC6A2—endocrine gland—alcohol dependence	0.000223	0.00434	CbGeAlD
Amphetamine—Dry mouth—Citalopram—alcohol dependence	0.000219	0.003	CcSEcCtD
Amphetamine—SLC22A5—blood—alcohol dependence	0.000218	0.00424	CbGeAlD
Amphetamine—CYP2D6—brainstem—alcohol dependence	0.000218	0.00424	CbGeAlD
Amphetamine—MAOB—liver—alcohol dependence	0.000217	0.00422	CbGeAlD
Amphetamine—MAOB—central nervous system—alcohol dependence	0.000217	0.00422	CbGeAlD
Amphetamine—Vomiting—Naltrexone—alcohol dependence	0.000216	0.00295	CcSEcCtD
Amphetamine—SLC22A5—midbrain—alcohol dependence	0.000216	0.00419	CbGeAlD
Amphetamine—Anaphylactic shock—Citalopram—alcohol dependence	0.000215	0.00294	CcSEcCtD
Amphetamine—Rash—Naltrexone—alcohol dependence	0.000214	0.00292	CcSEcCtD
Amphetamine—Dermatitis—Naltrexone—alcohol dependence	0.000214	0.00292	CcSEcCtD
Amphetamine—Infection—Citalopram—alcohol dependence	0.000214	0.00292	CcSEcCtD
Amphetamine—Nausea—Acamprosate—alcohol dependence	0.000213	0.00291	CcSEcCtD
Amphetamine—SLC6A2—testis—alcohol dependence	0.000213	0.00414	CbGeAlD
Amphetamine—Headache—Naltrexone—alcohol dependence	0.000213	0.00291	CcSEcCtD
Amphetamine—MAOB—cerebellum—alcohol dependence	0.000212	0.00412	CbGeAlD
Amphetamine—CYP2D6—forebrain—alcohol dependence	0.000211	0.00409	CbGeAlD
Amphetamine—Tachycardia—Citalopram—alcohol dependence	0.00021	0.00287	CcSEcCtD
Amphetamine—SLC6A2—nervous system—alcohol dependence	0.000209	0.00406	CbGeAlD
Amphetamine—Hyperhidrosis—Citalopram—alcohol dependence	0.000208	0.00284	CcSEcCtD
Amphetamine—Anorexia—Citalopram—alcohol dependence	0.000205	0.0028	CcSEcCtD
Amphetamine—DRD2—endocrine gland—alcohol dependence	0.000203	0.00395	CbGeAlD
Amphetamine—Nausea—Naltrexone—alcohol dependence	0.000202	0.00276	CcSEcCtD
Amphetamine—SLC6A2—central nervous system—alcohol dependence	0.000201	0.00391	CbGeAlD
Amphetamine—Phentermine—MAOB—alcohol dependence	0.000201	0.0447	CrCbGaD
Amphetamine—SLC6A3—brain—alcohol dependence	0.000198	0.00385	CbGeAlD
Amphetamine—Insomnia—Citalopram—alcohol dependence	0.000195	0.00266	CcSEcCtD
Amphetamine—Lisdexamfetamine—SLC6A3—alcohol dependence	0.000194	0.0432	CrCbGaD
Amphetamine—DRD2—testis—alcohol dependence	0.000194	0.00377	CbGeAlD
Amphetamine—Dyspnoea—Citalopram—alcohol dependence	0.000192	0.00262	CcSEcCtD
Amphetamine—Somnolence—Citalopram—alcohol dependence	0.000191	0.00261	CcSEcCtD
Amphetamine—DRD2—nervous system—alcohol dependence	0.00019	0.0037	CbGeAlD
Amphetamine—Dyspepsia—Citalopram—alcohol dependence	0.000189	0.00259	CcSEcCtD
Amphetamine—Decreased appetite—Citalopram—alcohol dependence	0.000187	0.00255	CcSEcCtD
Amphetamine—SLC22A3—brain—alcohol dependence	0.000186	0.00362	CbGeAlD
Amphetamine—Selegiline—MAOB—alcohol dependence	0.000186	0.0413	CrCbGaD
Amphetamine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000186	0.00254	CcSEcCtD
Amphetamine—Fatigue—Citalopram—alcohol dependence	0.000185	0.00253	CcSEcCtD
Amphetamine—Constipation—Citalopram—alcohol dependence	0.000184	0.00251	CcSEcCtD
Amphetamine—DRD2—central nervous system—alcohol dependence	0.000183	0.00356	CbGeAlD
Amphetamine—SLC6A4—brain—alcohol dependence	0.000181	0.00352	CbGeAlD
Amphetamine—SLC22A5—testis—alcohol dependence	0.000181	0.00351	CbGeAlD
Amphetamine—DRD2—cerebellum—alcohol dependence	0.000179	0.00348	CbGeAlD
Amphetamine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000176	0.0024	CcSEcCtD
Amphetamine—MAOB—brain—alcohol dependence	0.000172	0.00335	CbGeAlD
Amphetamine—Urticaria—Citalopram—alcohol dependence	0.000171	0.00233	CcSEcCtD
Amphetamine—SLC22A5—liver—alcohol dependence	0.000171	0.00332	CbGeAlD
Amphetamine—Body temperature increased—Citalopram—alcohol dependence	0.00017	0.00232	CcSEcCtD
Amphetamine—Abdominal pain—Citalopram—alcohol dependence	0.00017	0.00232	CcSEcCtD
Amphetamine—Tranylcypromine—MAOA—alcohol dependence	0.000168	0.0374	CrCbGaD
Amphetamine—SLC22A5—cerebellum—alcohol dependence	0.000167	0.00324	CbGeAlD
Amphetamine—Phenelzine—MAOB—alcohol dependence	0.000164	0.0364	CrCbGaD
Amphetamine—SLC6A2—brain—alcohol dependence	0.00016	0.0031	CbGeAlD
Amphetamine—Hypersensitivity—Citalopram—alcohol dependence	0.000158	0.00217	CcSEcCtD
Amphetamine—Phenylpropanolamine—MAOA—alcohol dependence	0.000158	0.0351	CrCbGaD
Amphetamine—Asthenia—Citalopram—alcohol dependence	0.000154	0.00211	CcSEcCtD
Amphetamine—CYP2D6—digestive system—alcohol dependence	0.000148	0.00287	CbGeAlD
Amphetamine—Diarrhoea—Citalopram—alcohol dependence	0.000147	0.00201	CcSEcCtD
Amphetamine—DRD2—brain—alcohol dependence	0.000145	0.00283	CbGeAlD
Amphetamine—Methamphetamine—MAOB—alcohol dependence	0.000143	0.0318	CrCbGaD
Amphetamine—Dizziness—Citalopram—alcohol dependence	0.000142	0.00194	CcSEcCtD
Amphetamine—CYP2D6—blood—alcohol dependence	0.000141	0.00274	CbGeAlD
Amphetamine—Phentermine—MAOA—alcohol dependence	0.000141	0.0313	CrCbGaD
Amphetamine—Vomiting—Citalopram—alcohol dependence	0.000137	0.00187	CcSEcCtD
Amphetamine—Phenylpropanolamine—SLC6A3—alcohol dependence	0.000136	0.0303	CrCbGaD
Amphetamine—Rash—Citalopram—alcohol dependence	0.000136	0.00185	CcSEcCtD
Amphetamine—Dermatitis—Citalopram—alcohol dependence	0.000135	0.00185	CcSEcCtD
Amphetamine—SLC22A5—brain—alcohol dependence	0.000135	0.00263	CbGeAlD
Amphetamine—Headache—Citalopram—alcohol dependence	0.000135	0.00184	CcSEcCtD
Amphetamine—Pseudoephedrine—MAOA—alcohol dependence	0.000133	0.0297	CrCbGaD
Amphetamine—Selegiline—MAOA—alcohol dependence	0.00013	0.029	CrCbGaD
Amphetamine—Nausea—Citalopram—alcohol dependence	0.000128	0.00175	CcSEcCtD
Amphetamine—CYP2D6—endocrine gland—alcohol dependence	0.000122	0.00237	CbGeAlD
Amphetamine—Phentermine—SLC6A3—alcohol dependence	0.000121	0.027	CrCbGaD
Amphetamine—CYP2D6—testis—alcohol dependence	0.000116	0.00226	CbGeAlD
Amphetamine—Dextroamphetamine—SLC6A3—alcohol dependence	0.000116	0.0258	CrCbGaD
Amphetamine—Pseudoephedrine—SLC6A3—alcohol dependence	0.000115	0.0256	CrCbGaD
Amphetamine—Phenelzine—MAOA—alcohol dependence	0.000115	0.0255	CrCbGaD
Amphetamine—CYP2D6—nervous system—alcohol dependence	0.000114	0.00222	CbGeAlD
Amphetamine—CYP2D6—liver—alcohol dependence	0.00011	0.00214	CbGeAlD
Amphetamine—CYP2D6—central nervous system—alcohol dependence	0.00011	0.00214	CbGeAlD
Amphetamine—CYP2D6—cerebellum—alcohol dependence	0.000108	0.00209	CbGeAlD
Amphetamine—Tranylcypromine—CYP2E1—alcohol dependence	0.000104	0.0231	CrCbGaD
Amphetamine—Methamphetamine—MAOA—alcohol dependence	0.0001	0.0223	CrCbGaD
Amphetamine—Phentermine—SLC6A4—alcohol dependence	9.08e-05	0.0202	CrCbGaD
Amphetamine—CYP2D6—brain—alcohol dependence	8.74e-05	0.0017	CbGeAlD
Amphetamine—Methamphetamine—SLC6A3—alcohol dependence	8.65e-05	0.0192	CrCbGaD
Amphetamine—Pseudoephedrine—SLC6A4—alcohol dependence	8.61e-05	0.0191	CrCbGaD
Amphetamine—Benzphetamine—SLC6A3—alcohol dependence	8.58e-05	0.0191	CrCbGaD
Amphetamine—Benzyl alcohol—CYP2E1—alcohol dependence	8.38e-05	0.0186	CrCbGaD
Amphetamine—Selegiline—CYP2E1—alcohol dependence	8.04e-05	0.0179	CrCbGaD
Amphetamine—CYP2A6—Biological oxidations—ALDH2—alcohol dependence	7.34e-05	0.000901	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—SLC6A4—alcohol dependence	7.31e-05	0.000898	CbGpPWpGaD
Amphetamine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	7.3e-05	0.000896	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—PDYN—alcohol dependence	7.25e-05	0.000891	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—NPY—alcohol dependence	7.14e-05	0.000876	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	7.14e-05	0.000876	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	7.11e-05	0.000873	CbGpPWpGaD
Amphetamine—Phenelzine—CYP2E1—alcohol dependence	7.08e-05	0.0158	CrCbGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	7.02e-05	0.000862	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ADH6—alcohol dependence	6.96e-05	0.000855	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CRH—alcohol dependence	6.89e-05	0.000845	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR1B—alcohol dependence	6.89e-05	0.000845	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—AVP—alcohol dependence	6.82e-05	0.000838	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—OPRK1—alcohol dependence	6.82e-05	0.000837	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	6.69e-05	0.000821	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—ADH7—alcohol dependence	6.66e-05	0.000818	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—DRD4—alcohol dependence	6.63e-05	0.000814	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—MAOA—alcohol dependence	6.58e-05	0.000808	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—AVP—alcohol dependence	6.56e-05	0.000806	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—SLC6A3—alcohol dependence	6.52e-05	0.0008	CbGpPWpGaD
Amphetamine—Methamphetamine—SLC6A4—alcohol dependence	6.47e-05	0.0144	CrCbGaD
Amphetamine—MAOB—Biological oxidations—POMC—alcohol dependence	6.45e-05	0.000792	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—GABRA2—alcohol dependence	6.41e-05	0.000787	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—GGT2—alcohol dependence	6.39e-05	0.000784	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—GABRA2—alcohol dependence	6.38e-05	0.000784	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CHRM2—alcohol dependence	6.34e-05	0.000778	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CNR1—alcohol dependence	6.33e-05	0.000777	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	6.19e-05	0.000761	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—DRD2—alcohol dependence	6.17e-05	0.000758	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HTR7—alcohol dependence	6.17e-05	0.000758	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	6.16e-05	0.000756	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—GGT1—alcohol dependence	6.14e-05	0.000754	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—POMC—alcohol dependence	6.11e-05	0.00075	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—DRD4—alcohol dependence	6.02e-05	0.000739	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	6.02e-05	0.000739	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—ALDH2—alcohol dependence	5.97e-05	0.000733	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—OPRD1—alcohol dependence	5.95e-05	0.000731	CbGpPWpGaD
Amphetamine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	5.92e-05	0.000726	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—AVP—alcohol dependence	5.9e-05	0.000725	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADH6—alcohol dependence	5.89e-05	0.000723	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	5.88e-05	0.000722	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—AVP—alcohol dependence	5.88e-05	0.000722	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—CYP2E1—alcohol dependence	5.87e-05	0.00072	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	5.86e-05	0.00072	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—CRH—alcohol dependence	5.86e-05	0.000719	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	5.84e-05	0.000717	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—OPRM1—alcohol dependence	5.82e-05	0.000715	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ADH1A—alcohol dependence	5.77e-05	0.000708	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	5.77e-05	0.000708	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CNR1—alcohol dependence	5.75e-05	0.000706	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PDYN—alcohol dependence	5.71e-05	0.000701	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—DRD2—alcohol dependence	5.61e-05	0.000688	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR7—alcohol dependence	5.61e-05	0.000688	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	5.55e-05	0.000682	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—SLC6A4—alcohol dependence	5.44e-05	0.000668	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	5.4e-05	0.000663	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—GGT1—alcohol dependence	5.39e-05	0.000661	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—NPY—alcohol dependence	5.36e-05	0.000658	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—WASF2—alcohol dependence	5.31e-05	0.000652	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CRHR1—alcohol dependence	5.31e-05	0.000652	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—AVP—alcohol dependence	5.2e-05	0.000638	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—GABRB1—alcohol dependence	5.19e-05	0.000638	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—HTR1B—alcohol dependence	5.17e-05	0.000635	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—alcohol dependence	5.12e-05	0.000629	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—DRD4—alcohol dependence	5.12e-05	0.000629	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	5.1e-05	0.000626	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—WASF1—alcohol dependence	5.09e-05	0.000625	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	5.04e-05	0.000619	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CHRM2—alcohol dependence	4.99e-05	0.000613	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	4.98e-05	0.000612	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ADH4—alcohol dependence	4.9e-05	0.000602	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADH1A—alcohol dependence	4.88e-05	0.000599	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—MAOB—alcohol dependence	4.84e-05	0.000594	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—MAOA—alcohol dependence	4.83e-05	0.000593	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	4.8e-05	0.000589	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—HTR7—alcohol dependence	4.77e-05	0.000586	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—AVP—alcohol dependence	4.72e-05	0.000579	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—GRIN2B—alcohol dependence	4.72e-05	0.000579	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	4.63e-05	0.000568	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—AVP—alcohol dependence	4.59e-05	0.000564	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—OPRM1—alcohol dependence	4.58e-05	0.000562	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—OPRD1—alcohol dependence	4.58e-05	0.000562	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—DRD4—alcohol dependence	4.52e-05	0.000555	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—GABRA2—alcohol dependence	4.42e-05	0.000542	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—PDYN—alcohol dependence	4.39e-05	0.000539	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HTR2A—alcohol dependence	4.32e-05	0.000531	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CNR1—alcohol dependence	4.31e-05	0.00053	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	4.26e-05	0.000523	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NPY—alcohol dependence	4.22e-05	0.000518	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	4.19e-05	0.000515	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	4.19e-05	0.000515	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ADH7—alcohol dependence	4.17e-05	0.000512	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADH4—alcohol dependence	4.15e-05	0.00051	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	4.12e-05	0.000505	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	4.11e-05	0.000505	CbGpPWpGaD
Amphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	4.09e-05	0.000503	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CRHR1—alcohol dependence	4.08e-05	0.000501	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—AVP—alcohol dependence	4.07e-05	0.0005	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR1B—alcohol dependence	4.07e-05	0.000499	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CRH—alcohol dependence	4.07e-05	0.000499	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—AVP—alcohol dependence	4.01e-05	0.000493	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	4e-05	0.000491	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GGT2—alcohol dependence	4e-05	0.000491	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR2A—alcohol dependence	3.93e-05	0.000482	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—MAOA—alcohol dependence	3.92e-05	0.000482	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	3.91e-05	0.00048	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—OPRK1—alcohol dependence	3.85e-05	0.000473	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CHRM2—alcohol dependence	3.84e-05	0.000471	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ADH1B—alcohol dependence	3.66e-05	0.000449	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	3.63e-05	0.000445	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	3.61e-05	0.000444	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	3.59e-05	0.000441	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—DRD4—alcohol dependence	3.56e-05	0.000437	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—EP300—alcohol dependence	3.54e-05	0.000435	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADH7—alcohol dependence	3.53e-05	0.000433	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—OPRM1—alcohol dependence	3.52e-05	0.000433	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—OPRK1—alcohol dependence	3.5e-05	0.000429	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—AVP—alcohol dependence	3.47e-05	0.000426	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—POMC—alcohol dependence	3.45e-05	0.000424	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	3.43e-05	0.000421	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CNR1—alcohol dependence	3.39e-05	0.000417	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADH6—alcohol dependence	3.39e-05	0.000416	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GGT2—alcohol dependence	3.38e-05	0.000415	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	3.35e-05	0.000411	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	3.32e-05	0.000407	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR7—alcohol dependence	3.31e-05	0.000407	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—DRD2—alcohol dependence	3.31e-05	0.000407	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	3.29e-05	0.000404	CbGpPWpGaD
Amphetamine—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	3.25e-05	0.000398	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—NPY—alcohol dependence	3.24e-05	0.000398	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—POMC—alcohol dependence	3.14e-05	0.000386	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—POMC—alcohol dependence	3.14e-05	0.000385	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR1B—alcohol dependence	3.13e-05	0.000384	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CRH—alcohol dependence	3.13e-05	0.000384	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADH1B—alcohol dependence	3.09e-05	0.00038	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—GGT1—alcohol dependence	3.02e-05	0.000371	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—AVP—alcohol dependence	3e-05	0.000368	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—AVP—alcohol dependence	2.99e-05	0.000367	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—EP300—alcohol dependence	2.89e-05	0.000355	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.82e-05	0.000346	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	2.82e-05	0.000346	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADH1A—alcohol dependence	2.81e-05	0.000345	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AVP—alcohol dependence	2.79e-05	0.000342	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	2.74e-05	0.000336	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—DRD4—alcohol dependence	2.74e-05	0.000336	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—MAOA—alcohol dependence	2.71e-05	0.000332	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CNR1—alcohol dependence	2.61e-05	0.000321	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—OPRD1—alcohol dependence	2.59e-05	0.000318	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALDH2—alcohol dependence	2.58e-05	0.000316	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MAOB—alcohol dependence	2.56e-05	0.000315	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR7—alcohol dependence	2.55e-05	0.000313	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PDYN—alcohol dependence	2.48e-05	0.000305	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADH4—alcohol dependence	2.39e-05	0.000293	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—POMC—alcohol dependence	2.35e-05	0.000289	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—OPRD1—alcohol dependence	2.35e-05	0.000289	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	2.34e-05	0.000288	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—AVP—alcohol dependence	2.33e-05	0.000287	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR2A—alcohol dependence	2.32e-05	0.000285	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CRHR1—alcohol dependence	2.31e-05	0.000283	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PDYN—alcohol dependence	2.25e-05	0.000277	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GOT2—alcohol dependence	2.19e-05	0.000269	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALDH2—alcohol dependence	2.18e-05	0.000268	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CHRM2—alcohol dependence	2.17e-05	0.000266	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—AVP—alcohol dependence	2.14e-05	0.000263	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CRHR1—alcohol dependence	2.1e-05	0.000257	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—AVP—alcohol dependence	2.07e-05	0.000254	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OPRK1—alcohol dependence	2.07e-05	0.000254	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP2E1—alcohol dependence	2.06e-05	0.000253	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADH7—alcohol dependence	2.03e-05	0.000249	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—OPRM1—alcohol dependence	1.99e-05	0.000245	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CHRM2—alcohol dependence	1.97e-05	0.000242	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GGT2—alcohol dependence	1.95e-05	0.000239	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADH6—alcohol dependence	1.9e-05	0.000234	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GOT1—alcohol dependence	1.89e-05	0.000232	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GGT1—alcohol dependence	1.89e-05	0.000232	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	1.87e-05	0.00023	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GOT2—alcohol dependence	1.85e-05	0.000228	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—POMC—alcohol dependence	1.85e-05	0.000227	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—NPY—alcohol dependence	1.83e-05	0.000225	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—OPRM1—alcohol dependence	1.81e-05	0.000222	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2A—alcohol dependence	1.78e-05	0.000219	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADH1B—alcohol dependence	1.78e-05	0.000219	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—EP300—alcohol dependence	1.77e-05	0.000217	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR1B—alcohol dependence	1.77e-05	0.000217	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CRH—alcohol dependence	1.77e-05	0.000217	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—alcohol dependence	1.76e-05	0.000216	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP2E1—alcohol dependence	1.74e-05	0.000214	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MAOA—alcohol dependence	1.69e-05	0.000208	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—NPY—alcohol dependence	1.66e-05	0.000204	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR1B—alcohol dependence	1.61e-05	0.000197	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CRH—alcohol dependence	1.61e-05	0.000197	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GGT1—alcohol dependence	1.6e-05	0.000196	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GOT1—alcohol dependence	1.6e-05	0.000196	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADH1A—alcohol dependence	1.58e-05	0.000193	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—DRD4—alcohol dependence	1.55e-05	0.00019	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MAOB—alcohol dependence	1.48e-05	0.000181	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CNR1—alcohol dependence	1.48e-05	0.000181	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR7—alcohol dependence	1.44e-05	0.000177	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MAOA—alcohol dependence	1.43e-05	0.000176	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—alcohol dependence	1.43e-05	0.000175	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—DRD4—alcohol dependence	1.4e-05	0.000172	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OPRD1—alcohol dependence	1.39e-05	0.00017	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CNR1—alcohol dependence	1.34e-05	0.000165	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADH4—alcohol dependence	1.34e-05	0.000165	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDYN—alcohol dependence	1.33e-05	0.000163	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR7—alcohol dependence	1.31e-05	0.000161	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALDH2—alcohol dependence	1.26e-05	0.000154	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CRHR1—alcohol dependence	1.24e-05	0.000152	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—WASF2—alcohol dependence	1.24e-05	0.000152	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EP300—alcohol dependence	1.23e-05	0.000151	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AVP—alcohol dependence	1.21e-05	0.000149	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—WASF1—alcohol dependence	1.19e-05	0.000146	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CHRM2—alcohol dependence	1.16e-05	0.000143	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADH7—alcohol dependence	1.14e-05	0.00014	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—alcohol dependence	1.1e-05	0.000135	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AVP—alcohol dependence	1.1e-05	0.000135	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GGT2—alcohol dependence	1.09e-05	0.000134	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OPRM1—alcohol dependence	1.07e-05	0.000131	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT2—alcohol dependence	1.07e-05	0.000131	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2A—alcohol dependence	1.01e-05	0.000124	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2E1—alcohol dependence	1e-05	0.000123	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADH1B—alcohol dependence	9.99e-06	0.000123	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NPY—alcohol dependence	9.83e-06	0.000121	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1B—alcohol dependence	9.49e-06	0.000116	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CRH—alcohol dependence	9.49e-06	0.000116	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—alcohol dependence	9.33e-06	0.000115	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT1—alcohol dependence	9.21e-06	0.000113	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GGT1—alcohol dependence	9.21e-06	0.000113	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—alcohol dependence	9.16e-06	0.000112	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD4—alcohol dependence	8.29e-06	0.000102	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MAOB—alcohol dependence	8.28e-06	0.000102	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MAOA—alcohol dependence	8.26e-06	0.000101	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—alcohol dependence	8.05e-06	9.89e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR1—alcohol dependence	7.92e-06	9.72e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR7—alcohol dependence	7.72e-06	9.48e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—EP300—alcohol dependence	7.32e-06	8.99e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—alcohol dependence	7.31e-06	8.98e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDH2—alcohol dependence	7.04e-06	8.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AVP—alcohol dependence	6.5e-06	7.98e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—EP300—alcohol dependence	6.19e-06	7.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT2—alcohol dependence	5.98e-06	7.35e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	5.63e-06	6.91e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—alcohol dependence	5.41e-06	6.64e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—alcohol dependence	5.37e-06	6.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GGT1—alcohol dependence	5.17e-06	6.34e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT1—alcohol dependence	5.17e-06	6.34e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MAOA—alcohol dependence	4.63e-06	5.68e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—alcohol dependence	4.32e-06	5.3e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—EP300—alcohol dependence	3.57e-06	4.38e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—alcohol dependence	3.01e-06	3.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EP300—alcohol dependence	2.87e-06	3.52e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—EP300—alcohol dependence	2e-06	2.45e-05	CbGpPWpGaD
